Anti-VEGF therapy prevents or restores vision loss by inhibiting the action of VEGF proteins that are abnormally produced in the eye due to retinal diseases, such as macular degeneration or diabetic macular edema, thereby preventing new blood vessel formation and blood leakage [9]. The gene discussed is VEGFA; the disease is macular degeneration.